Cabot (NYSE:CBT) Sets New 1-Year High – Should You Buy?

Cabot Corporation (NYSE:CBT)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $90.07 and last traded at $89.0090, with a volume of 16849 shares changing hands. The stock had previously closed at $89.21.

Analysts Set New Price Targets

CBT has been the topic of a number of research reports. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday. Mizuho boosted their price objective on Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, May 6th. JPMorgan Chase & Co. increased their target price on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Truist Financial began coverage on Cabot in a report on Monday, June 8th. They set a “buy” rating and a $98.00 target price for the company. Finally, UBS Group lifted their target price on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research report on Friday, May 8th. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $83.80.

Cabot Trading Down 0.2%

The company’s 50 day simple moving average is $80.36 and its 200 day simple moving average is $74.12. The firm has a market cap of $4.60 billion, a price-to-earnings ratio of 16.90, a P/E/G ratio of 11.53 and a beta of 0.82. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.31 million. During the same period last year, the business posted $1.90 earnings per share. Cabot’s revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, research analysts expect that Cabot Corporation will post 6.34 earnings per share for the current fiscal year.

Cabot Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were paid a dividend of $0.4725 per share. The ex-dividend date was Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.1%. Cabot’s payout ratio is currently 35.73%.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Fuller & Thaler Asset Management Inc. increased its position in shares of Cabot by 5.6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock valued at $155,315,000 after purchasing an additional 124,613 shares during the last quarter. State Street Corp raised its stake in Cabot by 1.0% during the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after acquiring an additional 20,021 shares in the last quarter. American Century Companies Inc. lifted its position in Cabot by 8.4% in the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock valued at $137,300,000 after acquiring an additional 140,665 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Cabot by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock valued at $131,253,000 after acquiring an additional 79,499 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in Cabot by 3.9% in the third quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock valued at $128,032,000 after acquiring an additional 63,080 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.